HomeInsightsStock Comparison

Epigral Ltd vs Yasons Chemex Care Ltd Stock Comparison

Epigral Ltd vs Yasons Chemex Care Ltd Stock Comparison

Last Updated on: Mar 18, 2026

Key Highlights

  • The Latest Trading Price of Epigral Ltd is ₹ 856.45 as of 18 Mar 15:30 . The P/E Ratio of Epigral Ltd changed from 16 on March 2022 to 22.9 on March 2025 . This represents a CAGR of 9.38% over 4 yearsThe P/E Ratio of Yasons Chemex Care Ltd changed from 39.7 on March 2024 to 15.3 on March 2025 . This represents a CAGR of -37.92% over 2 years The Market Cap of Epigral Ltd changed from ₹ 4045 crore on March 2022 to ₹ 8191 crore on March 2025 . This represents a CAGR of 19.29% over 4 yearsThe Market Cap of Yasons Chemex Care Ltd changed from ₹ 49.8 crore on March 2024 to ₹ 24.81 crore on March 2025 . This represents a CAGR of -29.42% over 2 years The revenue of Epigral Ltd for the Dec '25 is ₹ 602.68 crore as compare to the Sep '25 revenue of ₹ 589.1 crore. This represent the growth of 2.31% The revenue of Yasons Chemex Care Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Epigral Ltd for the Dec '25 is ₹ 108.26 crore as compare to the Sep '25 ebitda of ₹ 133.8 crore. This represent the decline of -19.09% The ebitda of Yasons Chemex Care Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Epigral Ltd changed from ₹ 85.87 crore to ₹ 39.11 crore over 7 quarters. This represents a CAGR of -36.20% The net profit of Yasons Chemex Care Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Epigral Ltd changed from 5.88 % on March 2023 to 7.26 % on March 2025 . This represents a CAGR of 7.28% over 3 yearsThe Dividend Payout of Yasons Chemex Care Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Epigral Ltd

  • Epigral Limited was erstwhile incorporated as 'Meghmani Finechem Limited' in 2007, which is engaged in manufacturing and selling of Chlor Alkali & its Derivatives and also in Trading of Agrochemical products.
  • The Company was incorporated as a subsidiary of Meghmani Organics Limited. Meghmani Finechem Limited (MFL) was demerged from Meghmani Organics Limited (MOL) as a going concern, through the Scheme of Arrangement for Demerger and the said Scheme became effective from May 10, 2021.
  • The Chlor-Alkali business commissioned in 2009, growing from an installed capacity of 1,88,000 TPA in 2015 to 3,15,000 TPA at the close of FY 2020-21.
  • The Company is now among the leading players in India's chlor alkali industry.
  • In terms of the said Scheme, the Company allotted 2,39,03,029 Equity Shares of Rs 10/- each on 20th May, 2021 to the shareholders of Meghmani Organics Limited.

About Yasons Chemex Care Ltd

  • Yasons Chemex Care Limited was incorporated on October 17, 2017 in Ahmedabad with the Registrar of Companies, Gujarat.
  • Company is a leading domestic dyestuff manufacturer in Gujarat, with production facilities strategically located in the chemical industrial zone.
  • This strategic location offers easy access to the Common Effluent Treatment Plant, fostering innovation and knowledge sharing.
  • Aside from lowering costs and improving supply chain management, the company's extensive industry knowledge and expertise enable its efficient transportation of raw materials and finished goods.
  • Company is renowned for producing premium dyestuffs, FMCG products, IMCG Products. Within dyes, the Company manufacture wide range of dyes such as reactive dyes, direct dyes, basic dyes, vat dyes and food colorants.

FAQs for the comparison of Epigral Ltd and Yasons Chemex Care Ltd

Which company has a larger market capitalization, Epigral Ltd or Yasons Chemex Care Ltd?

Market cap of Epigral Ltd is 3,694 Cr while Market cap of Yasons Chemex Care Ltd is 19 Cr

What are the key factors driving the stock performance of Epigral Ltd and Yasons Chemex Care Ltd?

The stock performance of Epigral Ltd and Yasons Chemex Care Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Epigral Ltd and Yasons Chemex Care Ltd?

As of March 18, 2026, the Epigral Ltd stock price is INR ₹856.45. On the other hand, Yasons Chemex Care Ltd stock price is INR ₹10.0.

How do dividend payouts of Epigral Ltd and Yasons Chemex Care Ltd compare?

To compare the dividend payouts of Epigral Ltd and Yasons Chemex Care Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions